Stefan Zbyn1,2, Vladimir Mlynarik1, Vladimir Juras1, Markus Schreiner1,3, Didier Laurent4, Joerg Goldhahn4, Nicole Getzmann4, Stefan Marlovits5, and Siegfried Trattnig1
1Department of Biomedical Imaging and Image-Guided Therapy, Medical University Vienna, Vienna, Austria, 2CD Laboratory for Clinical Molecular MR Imaging, Vienna, Austria, 3Department of Orthopaedics, Medical University Vienna, Vienna, Austria, 4Novartis Institutes for Biomedical Research, Basel, Switzerland, 5Department of Trauma Surgery, Medical University Vienna, Vienna, Austria
Synopsis
To our best
knowledge, this is the first report on employing sodium (23Na) MRI for the in vivo evaluation of low-grade
cartilage defects in the knee joint. In this 7T study, regions
with chondral defect, weight-bearing, and non-weight-bearing femoral
cartilage were evaluated in 23Na-images of patients after knee injury. Test-retest comparison showed high robustness and repeatability of sodium
data. 23Na-MRI allowed differentiation between normal-appearing cartilage and low-grade chondral defects. 23Na-MRI can be used for noninvasive follow-up of changes in GAG
content associated with cartilage degeneration. This method might be
particularly useful for the evaluation
of cartilage regenerating therapies.PURPOSE
Earliest stages
of cartilage degeneration were associated with decrease in glycosaminoglycan
concentration (GAG). It is hypothesized that cartilage degeneration might be
reversible in this early stages, thus a noninvasive evaluation of the GAG
content is highly desirable. Since the GAG molecules in cartilage are in
equilibrium with sodium (23Na) ions, in vitro experiments with controlled cartilage
degradation showed very high sensitivity of 23Na-MRI to even small changes in
GAG concentration.(1) Although 23Na-MRI was used for the evaluation
of GAG content in cartilage repair tissue(2) and in osteoarthritic
cartilage(3), this method has not yet been employed for the
evaluation of untreated posttraumatic low-grade chondral defects.
Thus, the aim of this 7T study was: i) to
evaluate the reproducibility of 23Na-MRI by comparing data obtained at baseline
and at 8-days follow-up in patients with chondral defects; ii) to compare 23Na-values
between defects and normal-appearing femoral cartilage in weight and non-weight
bearing region.
METHODS
Institutional Review Board approval and
informed consent from all patients were obtained. Six patients (4 females, 2
males; mean age, 51.5±5.0 years) with untreated chondral defects of ICRS grade
1 or 2 in the femoral cartilage (4 right and 2 left knees; 1 trochlea, 3 lateral and 2
medial condyles) were included in this study. All MRI scans were acquired at 7T
whole body system (Magnetom, Siemens Healthcare, Germany). T2-weighted 3D DESS
images with water excitation (resolution= 0.5×0.5×0.5 mm3;
TR/TE= 8.68/2.55 ms; measurement time= 3:58 minutes) (Fig.1) were acquired using a 28-channel knee array coil
(Quality Electrodynamics, OH). 23Na-images were acquired using a spoiled
gradient echo sequence with variable echo time
scheme (vTE-GRE)(4) optimized for 23Na-MRI of cartilage
(resolution= 1.6×1.6×3.0 mm3; TR= 9.2 ms; TEmin/TEmax= 1.22/1.82 ms;
flip angle= 51 degrees; bandwidth= 100 Hz/pixel; measurement time= 25 minutes) (Fig.1) using a 15-channel 23Na-only
knee array coil (Quality Electrodynamics, OH).
A radiologist with 24 years of experience in musculoskeletal
MRI identified one ICRS grade 1-2 cartilage defect for each patient on morphological
images from a routine 3T exam and selected corresponding DESS images that were
used for manual segmentation of cartilage and for measurements of cartilage thickness (Fig.1). Corresponding 23Na-images
were corrected for the spatially variable sensitivity of the knee coil using
measurements of a homogeneous phantom and Matlab scripts (Mathworks, MA).
All regions-of-interest (ROI) were drawn on DESS
images and transferred to the corresponding 23Na-images. In each patient, ROI analyses were performed in a chondral
defect, in weight-bearing and in non-weight bearing regions of normal-appearing femoral cartilage on three
consecutive 23Na-slices using the JiveX viewer (VISUS
GmbH, Germany). Mean 23Na-signal intensities were normalized
using a factor derived from the signal intensity of
the reference sample attached to knee coil and measured with each patient. The
corrected signal intensities (cSI) were calculated by dividing the normalized
signal intensities (nSI) with correction factors for partial volume effects
(PVEcf) obtained by fitting the cartilage thickness in ROI to a function describing
the signal attenuation in 23Na-image with a 2 mm resolution (Fig.2).(5) Intra-class
correlation coefficients and paired t-tests were calculated in the IBM SPSS statistic software.
RESULTS
The mean cartilage thickness was not significantly
different in the defect (3.1±0.5mm), weight-bearing (2.4±0.1mm), and non-weight-bearing
ROIs (2.7±0.3mm) (all p-values >0.087). The mean and standard deviation of 23Na-nSI
and 23Na-cSI values from weight-bearing, non-weight-bearing and defect ROIs are
shown in Table1. The intra-class
correlation coefficient was 0.95 for both, 23Na-nSI and 23Na-cSI values. No
significant differences were observed in 23Na-nSI values between defect, weight-bearing,
and non-weight-bearing ROIs at baseline and at 8-days follow-up (all p>0.224)
(Fig.3). However, 23Na-cSI values
showed significant differences between weight-bearing zone and defect at
baseline (p=0.047) and at 8-days follow-up (p=0.011) (Fig.4). Other differences in 23Na-cSI values were not statistically
significant.
DISCUSSION
Our preliminary
results demonstrate the ability of 23Na-MRI to differentiate between normally appearing cartilage and low-grade chondral defects (ICRS grade 1 or
2). This underlines high sensitivity of 23Na-MRI to small changes in GAG
content that was shown in previous in vitro studies.(1) However, due to low resolution of sodium
images, correction for partial volume effects is necessary for visualization of
GAG differences. Our data from baseline and 8-days follow-up showed that 23Na-MRI
at 7T can offer very robust and repeatable results. This is an ongoing study
that aims to measure up to 20 patients with additional follow-up measurement
after three months.
CONCLUSION
23Na-MRI can be used
for noninvasive follow-up of cartilage degeneration
based on monitoring of changes in GAG content in patients with low-grade cartilage defects. 23Na-MRI data
may serve as a helpful biomarker for the evaluation of cartilage regenerating
therapies.
Acknowledgements
Funding support provided by Austrian Science Fund (FWF) P 25246 B24.References
(1) Borthakur A., et al., Sensitivity
of MRI to proteoglycan depletion in cartilage: comparison of sodium and proton
MRI. Osteoarthritis Cartilage. 2000;8:288-93.
(2)
Zbyn S, et al., Evaluation of native hyaline cartilage
and repair tissue after two cartilage repair surgery techniques with 23Na MR
imaging at 7 T: initial experience. Osteoarthritis Cartilage. 2012;20:837-45.
(3) Madelin G., et
al., Articular Cartilage: Evaluation with Fluid-suppressed 7.0-T Sodium MR Imaging
in Subjects with and Subjects without Osteoarthritis. Radiol. 2013;268,481-91.
(4) Deligianni X., et al., High-Resolution
Fourier-Encoded Sub-Millisecond Echo Time Musculoskeletal Imaging at 3 Tesla
and 7 Tesla. Magn Reson Med.
2013;70,1434-39.
(5) Moon C.H., et
al., Quantitative 23Na MRI of Human Knee
Cartilage Using Dual-Tuned 1H/23Na Transceiver Array Radiofrequency Coil at 7
Tesla. J Magn Reson Imaging.
2013;38,1063-72.